Key points
Etoricoxib (Arcoxia) is a selective COX-2 inhibitor (coxib) and carries the best figure of any non-opioid painkiller covered by the Cochrane single-dose reviews.
| Where | How it helps | What human studies showed |
|---|---|---|
| Acute postoperative pain | a single 120 mg dose at least halves the pain in most people | 120 mg dose: 66% had their pain at least halved, against 12% on placebo, over six hours; NNT 1.8 (95% CI 1.7–2.0) — best among non-opioids; 6 studies, 798 participants, high certainty |
| Dental pain | a result of the same high level | dental studies: NNT 1.6 (95% CI 1.5–1.8) |
How it helps
Acute postoperative pain
An NNT of 1.8 means that fewer than two people need treating for one of them, over and above placebo, to have their pain at least halved. The result was obtained after a single 120 mg dose, over six hours.
Dental pain
The figure for dental studies was calculated separately: an NNT of 1.6 (95% CI 1.5–1.8) — at the same high level as the overall 1.8 (1.7–2.0).
Its place among other painkillers
The Cochrane overview pooled 39 reviews, some 460 studies and roughly 50,000 participants. Of the five drugs in this series, etoricoxib is the only one whose interval does not overlap those of naproxen and ketoprofen: it separates from the bottom of the list.
Gentler on the stomach
Etoricoxib selectively inhibits COX-2, so the stomach tolerates it better than non-selective NSAIDs.
How to take it
Etoricoxib is prescription-only; the doses are 30, 60, 90 and 120 mg.
An important detail about the 120 mg. In the European Union that dose is authorised only for an acute attack of gouty arthritis, and only as a short course. Other indications use the smaller strengths.
Where it is sold
- Germany — registered, prescription-only.
- France — registered, prescription-only; 30 and 60 mg plus generics.
- Italy — 384 packs under sixteen trade names (Arcoxia, Algix, Tauxib and generics), doses of 30, 60, 90 and 120 mg. Not one over-the-counter pack.
The drug is in the catalogue: Arcoxia (etoricoxib) 90 mg. No price is shown — prescription medicines are ordered through the chat, and the administrator confirms availability and cost.
Who should see a doctor first
Selective action on COX-2 does not cancel the class effects of NSAIDs, and those are worth knowing:
- Cardiovascular risk. Under the EU product information, etoricoxib is contraindicated in established coronary heart disease, peripheral arterial disease and/or cerebrovascular disease (including previous stroke), heart failure (NYHA II–IV) and hypertension with blood pressure persistently above 140/90 mmHg and not adequately controlled.
- Blood pressure. The drug can raise it; monitoring is needed in hypertension.
- Kidneys. Like all NSAIDs it reduces renal blood flow; caution in chronic kidney disease and dehydration.
- Never take two NSAIDs together. The analgesia does not add up; the risk to stomach and kidneys does.
It is prescription-only in all three countries, and the decision belongs to a doctor weighing cardiovascular risk, blood pressure and kidney function.
Bottom line
Etoricoxib is legitimately a strong drug, and its figure is honest: the best NNT among non-opioid painkillers in acute pain after surgery. That makes it a sound choice where pain is expected to be severe and short.
Source: Etoricoxib (Arcoxia): The Strongest Non-Opioid — and What That Actually Means — universum.earth. Dr. Pereligyn.
